Aardvark Therapeutics, Inc. (AARD) reporting calendar
Aardvark Therapeutics, Inc. files periodic reports with the SEC as AARD on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 18 Jul 2026 – 8 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 6
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open AARD market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-210675 |
| 10-K | 31 Dec 2025 | 23 Mar 2026 | 82 days | 0001193125-26-119770 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001193125-25-280260 |
| 10-Q | 30 Jun 2025 | 13 Aug 2025 | 44 days | 0000950170-25-108116 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0000950170-25-071560 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0000950170-25-047835 |
Source: SEC EDGAR company submissions for CIK 0001774857. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.